Participate in Share Chat. Set up virtual watchlists and portfolios See more trades and share info.
Register for FREE Now
Dechra Pharmaceuticals said annual growth of 2.3% was driven by its US business, where its key products delivered a strong performance. In the year ...
Create a free LSE account to:
Already have an account? Sign In
Don't have an account? Register for FREE